Armata Pharmaceuticals, Inc.

AMEX:ARMP

2.22 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220092008200720062005200420032002200120001999199819971996199519941993
Revenue 04.5295.5084.4740.823000.1150.260.4750.4090.3250.66412.1718.71810.3329.8646.8749.65214.07319.33318.8811.4036.87.20.92.30.10.40.1
Cost of Revenue 033.770.89220.01514.4441.3511.3510.3740.369000012.17100000000-1.775-1.6-1.6-1.6-1.9-1.4-1.3-0.4
Gross Profit 0-29.2414.616-15.541-13.621-1.351-1.351-0.259-0.1090.4750.4090.3250.66408.71810.3329.8646.8749.65214.07319.33318.8813.1778.48.82.54.21.51.70.5
Gross Profit Ratio 0-6.4560.838-3.474-16.5500-2.252-0.41911110111111111.1561.2351.2222.7781.826154.255
Reseach & Development Expenses 34.42633.7735.01720.01514.4449.8244.8922.8815.6783.9925.8056.5021.48015.18317.70914.48218.19917.28817.19731.31531.54619.31214.313.31311.58.26.80
General & Administrative Expenses 13.18411.6497.4378.2817.9669.2655.7027.598.4136.4216.858.8093.20805.8227.0296.3826.3136.655.498,067,0006.20300000000
Selling & Marketing Expenses 0000000000.2891.864000000000-8,066,991.933000000000
SG&A 13.18411.6497.4378.2817.9669.2655.7027.598.4136.718.7148.8093.20805.8227.0296.3826.3136.655.498.0676.2035.7083.632.82.92.31.95.5
Other Expenses 0-33.77-5.508-4.474-0.823-0.8441.930.006-0.554-0.3021.86400.13310.4818.882.14823.7231.7090.8845.190.3659.7353.4611.61.61.61.91.41.30.4
Operating Expenses 47.6111.64936.94623.82221.58719.08910.59410.47114.09110.70214.51915.3114.68810.48121.00524.73844.58724.51223.93822.68739.74747.48428.4819.517.917.416.311.9105.9
Operating Income -42.436-40.89-36.946-23.822-21.587-19.752-12.524-16.156-23.378-10.227-14.11-14.986-4.0241.69-21.167-16.554-36.729-19.347-15.17-13.804-22.741-28.604-15.303-11.1-9.1-14.9-12.1-10.4-8.3-5.4
Operating Income Ratio 0-9.028-6.708-5.325-26.2300-140.487-89.915-21.531-34.499-46.111-6.060.139-2.428-1.602-3.724-2.815-1.572-0.981-1.176-1.515-1.342-1.632-1.264-16.556-5.261-104-20.75-54
Total Other Income Expenses Net 23.52-28.1550.0290.667-0.5940.273-4.1782.0163.9849.63837.219-43.425-0.2366.2580.4470.4272.7390.1490.913-1.029-3.4435.1-28.406-2.80.71.1-13.50.88.30.4
Income Before Tax -18.916-69.045-36.917-23.155-22.181-19.479-12.438-14.14-19.394-0.58923.109-58.411-4.267.948-20.72-16.127-33.99-19.198-14.257-14.833-23.767-27.17-47.656-26.7-8.7-14.2-26-9.9-8.4-5.1
Income Before Tax Ratio 0-15.245-6.702-5.175-26.95100-122.957-74.592-1.2456.501-179.726-6.4160.653-2.377-1.561-3.446-2.793-1.477-1.054-1.229-1.439-4.179-3.926-1.208-15.778-11.304-99-21-51
Income Tax Expense 00-0.0290.0640.634-0.454-0.328-1.302-0.556-0.073-37.21943.425-3.15020.7216.12733.9919.19814.25714.83323.76727.1747.65626.78.714.2269.98.45.1
Net Income -18.916-69.045-36.888-23.219-22.815-19.025-12.11-12.838-18.838-0.51623.109-58.411-1.117.948-20.72-16.127-33.99-19.198-14.257-14.833-23.767-27.17-47.656-26.7-8.7-14.2-26-9.9-8.4-5.1
Net Income Ratio 0-15.245-6.697-5.19-27.72200-111.635-72.454-1.08656.501-179.726-1.6720.653-2.377-1.561-3.446-2.793-1.477-1.054-1.229-1.439-4.179-3.926-1.208-15.778-11.304-99-21-51
EPS -0.52-1.91-1.08-0.96-1.39-2.43-8.9-28.14-268.06-13.35589.4-4,040.33-161.762,705.45-7,270.18-6,842.17-24,313.3-15,697.47-12,561.23-1,290.16-2,596.63-3,092.77-6,312.01-4,149.83-1,633.19-3,515.72-7,924.41-4,700.85-7,000-195.58
EPS Diluted -0.32-1.91-1.08-0.96-1.39-2.43-8.9-27.34-268.06-13.35-326.2-4,040.33-161.762,705.45-7,270.18-6,842.17-24,313.3-15,697.47-12,561.23-1,290.16-2,596.63-3,092.77-6,312.01-4,149.83-1,633.19-3,515.72-7,924.41-4,700.85-7,000-195.58
EBITDA -42.436-39.918-36.054-22.653-20.439-19.752-9.54-9.982-13.462-10.227-14.11-61.601-3.8617.948-11.771-13.804-32.859-17.367-12.492-6.194-16.8-19.912-42.344-9.5-7.5-13.3-10.2-9-7-5
EBITDA Ratio 0-8.814-6.546-5.063-24.83500-86.8-51.777-21.531-34.499-189.542-5.8150.653-1.35-1.336-3.331-2.526-1.294-0.44-0.869-1.055-3.714-1.397-1.042-14.778-4.435-90-17.5-50